Ketamine Completed Phase 4 Trials for Healthy Controls Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02134951Biomarker Assessment of Glutamatergic Target Engagement